Insider · CIK 0001340610

Reynolds Cameron John

Reports to the SEC for 1 company · HENDERSON, NV

sec.gov

Transactions

Companies

Filings

CIK

0001340610

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-02-26	VNRXVOLITIONRX LTDA Award	Director, President and CEO	AAward	+486K sh	—	—	3,115,547
2026-01-22	VNRXVOLITIONRX LTDA Award	Director, President and CEO	AAward	+74.7K sh	—	—	2,629,547
2025-11-17	VNRXVOLITIONRX LTDP Purchase	Director, President and CEO	PPurchase	+20K sh	$0.35	+$7,000	2,554,847
2025-10-14	VNRXVOLITIONRX LTDP Purchase	Director, President and CEO	PPurchase	+110K sh	$0.51	+$56.1K	2,534,847
2025-10-14	VNRXVOLITIONRX LTD · Warrant (Right to Buy)P Purchase	Director, President and CEO	PPurchase	+110K sh	$0.01	+$1,100	110,000
2025-09-12	VNRXVOLITIONRX LTDP Purchase	Director, President and CEO	PPurchase	+15K sh	$0.66	+$9,885	2,624,847
2025-08-05	VNRXVOLITIONRX LTDP Purchase	Director, President and CEO	PPurchase	+78.1K sh	$0.64	+$50K	2,609,847
2025-07-24	VNRXVOLITIONRX LTDA Award	Director, President and CEO	AAward	+200K sh	—	—	2,531,722
2025-06-12	VNRXVOLITIONRX LTDP Purchase	Director, President and CEO	PPurchase	+12.5K sh	$0.59	+$7,372.5	2,331,722
2025-05-19	VNRXVOLITIONRX LTDP Purchase	Director, President and CEO	PPurchase	+20K sh	$0.44	+$8,730	2,319,222
2025-03-26	VNRXVOLITIONRX LTDP Purchase	Director, President and CEO	PPurchase	+182K sh	$0.55	+$100K	2,299,222
2025-01-29	VNRXVOLITIONRX LTD · Stock Option (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−50K sh	—	—	0
2025-01-29	VNRXVOLITIONRX LTD · Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+50K sh	—	—	50,000
2024-12-09	VNRXVOLITIONRX LTDP Purchase	Director, President and CEO	PPurchase	+140K sh	$0.57	+$80K	2,117,404
2024-09-01	VNRXVOLITIONRX LTDA Award	Director, President and CEO	AAward	+103K sh	—	—	1,977,593
2024-08-15	VNRXVOLITIONRX LTDA Award	Director, President and CEO	AAward	+29.5K sh	—	—	1,874,350
2024-06-01	VNRXVOLITIONRX LTDA Award	Director, President and CEO	AAward	+90.2K sh	—	—	1,844,850
2024-01-24	VNRXVOLITIONRX LTDA Award	Director, President and CEO	AAward	+50.2K sh	—	—	1,754,668
2023-12-08	VNRXVOLITIONRX LTDP Purchase	Director, President and CEO	PPurchase	+10K sh	$0.67	+$6,700	1,704,518
2023-10-19	VNRXVOLITIONRX LTDA Award	Director, President and CEO	AAward	+200K sh	—	—	1,694,518
2023-08-16	VNRXVOLITIONRX LTDP Purchase	Director, President and CEO	PPurchase	+10K sh	$1.22	+$12.2K	1,494,518
2023-07-05	VNRXVOLITIONRX LTDA Award	Director, President and CEO	AAward	+40.1K sh	—	—	1,484,518
2023-01-12	VNRXVOLITIONRX LTDA Award	Director, President and CEO	AAward	+33.4K sh	—	—	1,444,468
2022-10-13	VNRXVOLITIONRX LTDA Award	Director, President and CEO	AAward	+15.6K sh	—	—	1,411,093
2022-10-04	VNRXVOLITIONRX LTDA Award	Director, President and CEO	AAward	+200K sh	—	—	1,395,518
2022-08-30	VNRXVOLITIONRX LTDP Purchase	Director, President and CEO	PPurchase	+3,500 sh	$1.61	+$5,635	1,195,518
2022-06-23	VNRXVOLITIONRX LTDA Award	Director, President and CEO	AAward	+32.3K sh	—	—	1,192,018
2022-06-23	VNRXVOLITIONRX LTD · Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+59.5K sh	—	—	91,486
2022-04-07	VNRXVOLITIONRX LTDA Award	Director, President and CEO	AAward	+17.4K sh	—	—	1,159,748
2022-04-07	VNRXVOLITIONRX LTD · Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+32K sh	—	—	32,020
2021-12-08	VNRXVOLITIONRX LTD · Stock Option (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−85K sh	—	—	0
2021-12-08	VNRXVOLITIONRX LTD · Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+85K sh	—	—	85,000
2021-11-03	VNRXVOLITIONRX LTD · Stock Option (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−125K sh	—	—	0
2021-11-03	VNRXVOLITIONRX LTD · Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+125K sh	—	—	125,000
2021-11-03	VNRXVOLITIONRX LTD · Stock Option (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−100K sh	—	—	0
2021-11-03	VNRXVOLITIONRX LTD · Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+100K sh	—	—	100,000
2021-11-03	VNRXVOLITIONRX LTD · Stock Option (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−75K sh	—	—	0
2021-11-03	VNRXVOLITIONRX LTD · Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+75K sh	—	—	75,000
2021-07-14	VNRXVOLITIONRX LTD · Stock Option (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−55K sh	—	—	0
2021-07-14	VNRXVOLITIONRX LTD · Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+55K sh	—	—	55,000
2020-07-21	VNRXVOLITIONRX LTDM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+50K sh	$2.50	+$125K	1,176,273
2020-07-21	VNRXVOLITIONRX LTDF Tax Payment	Director, President and CEO	FTax Payment	−40.3K sh	$3.95	−$159K	1,136,000
2020-07-21	VNRXVOLITIONRX LTDM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+50K sh	$3.00	+$150K	1,186,000
2020-07-21	VNRXVOLITIONRX LTDF Tax Payment	Director, President and CEO	FTax Payment	−43.6K sh	$3.95	−$172K	1,142,373
2020-07-21	VNRXVOLITIONRX LTD · Stock Option (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−50K sh	—	—	0
2020-07-21	VNRXVOLITIONRX LTD · Stock Option (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−50K sh	—	—	0
2020-05-22	VNRXVOLITIONRX LTDP Purchase	Director, President and CEO	PPurchase	+4,000 sh	$2.75	+$11K	1,126,273
2020-04-13	VNRXVOLITIONRX LTD · Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+85K sh	—	—	85,000
2019-12-05	VNRXVOLITIONRX LTDP Purchase	Director, President and CEO	PPurchase	+1,100 sh	$4.24	+$4,664	1,122,273
2019-02-11	VNRXVOLITIONRX LTD · Stock Options (Right to Buy)A Award	Director, President and CEO	AAward	+50K sh	—	—	50,000

Recent filings

Accepted (ET)
Feb 274
Reynolds Cameron John0001477932-26-001103
SEC(opens sec.gov)
Jan 234
Reynolds Cameron John0001477932-26-000370
SEC(opens sec.gov)
Nov 174
Reynolds Cameron John0001477932-25-008380
SEC(opens sec.gov)
Oct 154
Reynolds Cameron John0001477932-25-007588
SEC(opens sec.gov)
Sep 154
Reynolds Cameron John0001477932-25-006725
SEC(opens sec.gov)
Aug 64
Reynolds Cameron John0001477932-25-005494
SEC(opens sec.gov)
Jul 254
Reynolds Cameron John0001477932-25-005250
SEC(opens sec.gov)
Jun 164
Reynolds Cameron John0001477932-25-004603
SEC(opens sec.gov)
May 194
Reynolds Cameron John0001477932-25-003959
SEC(opens sec.gov)
Mar 274
Reynolds Cameron John0001477932-25-002073
SEC(opens sec.gov)
Jan 314
Reynolds Cameron John0001477932-25-000614
SEC(opens sec.gov)
Dec 104
Reynolds Cameron John0001477932-24-007969
SEC(opens sec.gov)
Sep 44
Reynolds Cameron John0001477932-24-005502
SEC(opens sec.gov)
Aug 164
Reynolds Cameron John0001477932-24-005024
SEC(opens sec.gov)
Jun 44
Reynolds Cameron John0001477932-24-003488
SEC(opens sec.gov)
Jan 264
Reynolds Cameron John0001477932-24-000401
SEC(opens sec.gov)
Dec 114
Reynolds Cameron John0001477932-23-009055
SEC(opens sec.gov)
Oct 204
Reynolds Cameron John0001477932-23-007778
SEC(opens sec.gov)

Companies

VOLITIONRX LTDDirector, President and CEOVNRX

Address

1489 WEST WARM SPRINGS ROAD SUITE 110

HENDERSON, NV, 89014